Patent details

EP3687513 Title: TREATMENT OF FRAGILE X SYNDROME AND AUTISM WITH CANNABIDIOL

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP3687513
WO Application Number:
IB2018057519
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP18788905.0
WO Publication Number:
WO2019064234
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
27/09/2018
Grant date:
15/12/2021
EP Publication Date:
05/08/2020
WO Publication Date:
04/04/2019
Claims Translations Received Date:
Claims Translation B1 Received Date:
23/02/2022
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
15/12/2021
EP B1 Publication Date:
15/12/2021
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
26/09/2038
Lapsed By Expiration Date:
Patent Validated Date:
08/03/2022
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
20/02/2025
 
 

 

Name:
Harmony Biosciences Management, Inc.
Address:
630 W. Germantown Pike, Suite 215, 19462, Plymouth Meeting, PA, United States of America (US)

Historical Applicant/holder

From:
21/11/2024
To:
20/02/2025

 

Name:
Harmony Biosciences Management, Inc.
Address:
80 W. Lancaster Avenue, Suite 300, 19333, Devon, PA, United States of America (US)

From:
15/12/2021
To:
21/11/2024

 

Name:
Zynerba Pharmaceuticals, Inc.
Address:
80 W. Lancaster Avenue, Suite 300, Devon, PA 19333, United States of America (US)

Agent

Name:
dr. ir. F.M. van Bouwelen
From:
07/03/2022
Address:
Hoffmann Eitle B.V. Weerdestein 97, 1083 GG, AMSTERDAM, Netherlands (NL)
To:

Inventor

1

Name:
BONN-MILLER, Marcel
Address:
Lexington, NC 27292, United States of America (US)

2

Name:
TICH, Nancy
Address:
St. Paul, MN 55102, United States of America (US)

3

Name:
GUTTERMAN, Donna
Address:
Raleigh, NC 27615, United States of America (US)

4

Name:
MESSENHEIMER, John
Address:
Moncure, NC 27599, United States of America (US)

5

Name:
SEBREE, Terri
Address:
Gladwyne, PA 19035, United States of America (US)

Priority

1

Priority Patent Number:
201862632532 P
Priority Date:
20/02/2018
Priority Country:
United States of America (US)

2

Priority Patent Number:
201762564834 P
Priority Date:
28/09/2017
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 31/05; A61P 25/00;

Publication

Bulletin

1

Bulletin Heading:
CO
Journal edition number:
49/24
Publication date:
04/12/2024
Description:
Changes in the Netherlands Patent Register

2

Bulletin Heading:
EP3
Journal edition number:
10/22
Publication date:
09/03/2022
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

3

Bulletin Heading:
EP2
Journal edition number:
50/21
Publication date:
15/12/2021
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
202150
Publication date:
15/12/2021
Description:
Grant (B1)

Deed

Change of Address

Change Kind/ Decision Type:
Owner
Deed Number:
RC202500377A
Date Registered:
20/02/2025
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
dr. ir. F.M. van Bouwelen
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name
Deed Number:
RC202402140A
Date Registered:
21/11/2024
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
dr. ir. F.M. van Bouwelen
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Harmony Biosciences Management, Inc.
Address:
80 W. Lancaster Avenue, Suite 300, 19333, Devon, PA, United States of America (US)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
30/09/2026
Annual Fee Number:
9
Annual Fee Amount:
340 Euro
Last Annual Payment Date:
26/09/2025
Last Annual Fee Paid Number:
8
Last Annual Fee Paid Amount:
280 Euro
Payer:
Computer Packages Inc. (CPI)
Filing date Document type Document Description Number of pages File Type
07/03/2022 Outgoing Correspondence Letter no formal defects 2 PDF /7/1/3/3/5/0800753317/docs/ep18788905.0_1_466493l271.pdf
23/02/2022 Claims First filed claims 3 PDF /7/1/3/3/5/0800753317/docs/ep18788905.0_0_claims20220223144506617.pdf